Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Blue Owl Capital Holdings LP (CIK 1858703) reported $372.2M across 69 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ($56.6M, 15.20%), LRMR ($32.0M, 8.61%), ENGN ($30.1M, 8.08%), NCDL ($27.3M, 7.33%), CGEM ($27.1M, 7.29%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AKTIS ONCOLOGY INC | $56.6M | 15.20% | 3.2M | New | |
| 2 | LRMR | LARIMAR THERAPEUTICS INC | $32.0M | 8.61% | 7.1M | Added |
| 3 | ENGN | ENGENE HOLDINGS INC | $30.1M | 8.08% | 4.4M | Added |
| 4 | NCDL | NUVEEN CHURCHILL DIRECT LEND | $27.3M | 7.33% | 2.1M | Hold |
| 5 | CGEM | CULLINAN THERAPEUTICS INC | $27.1M | 7.29% | 1.9M | Trimmed |
| 6 | OBDC | BLUE OWL CAPITAL CORPORATION | $22.6M | 6.08% | 2.0M | Hold |
| 7 | MAPLIGHT THERAPEUTICS INC | $20.5M | 5.49% | 1.0M | Added | |
| 8 | CMPX | COMPASS THERAPEUTICS INC | $15.6M | 4.18% | 2.9M | Trimmed |
| 9 | CNTX | CONTEXT THERAPEUTICS INC | $13.3M | 3.58% | 5.1M | Trimmed |
| 10 | HLLY | HOLLEY INC | $13.0M | 3.49% | 4.2M | Added |
| 11 | EYPT | EYEPOINT INC | $11.8M | 3.16% | 912,594 | Added |
| 12 | CRVS | CORVUS PHARMACEUTICALS INC | $8.0M | 2.14% | 545,000 | New |
| 13 | CNDT | CONDUENT INC | $6.4M | 1.73% | 5.0M | Added |
| 14 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $6.3M | 1.70% | 302,638 | Added |
| 15 | AQST | AQUESTIVE THERAPEUTICS INC | $5.6M | 1.50% | 1.3M | Added |
| 16 | RYTM | RHYTHM PHARMACEUTICALS INC | $5.3M | 1.44% | 61,455 | New |
| 17 | CMPS | COMPASS PATHWAYS PLC | $5.1M | 1.38% | 1.8M | New |
| 18 | IMMX | IMMIX BIOPHARMA INC | $5.0M | 1.34% | 547,552 | Trimmed |
| 19 | IKNA | IMAGENEBIO INC | $4.8M | 1.29% | 959,337 | Added |
| 20 | CVEO | CIVEO CORP CDA | $4.8M | 1.28% | 180,475 | Trimmed |
| 21 | LENZ | LENZ THERAPEUTICS INC | $4.6M | 1.25% | 506,722 | Added |
| 22 | ELDN | ELEDON PHARMACEUTICALS INC | $4.4M | 1.18% | 1.4M | Trimmed |
| 23 | KALV | KALVISTA PHARMACEUTICALS INC | $4.3M | 1.16% | 215,000 | Trimmed |
| 24 | OVID | OVID THERAPEUTICS INC | $4.2M | 1.14% | 1.9M | New |
| 25 | PVLA | PALVELLA THERAPEUTICS INC NE | $3.9M | 1.05% | 31,259 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31